June 2026
The global breast cancer therapeutics market size was valued at USD 33.45 billion in 2025 and is expected to hit around USD 66.72 billion by 2035, at a CAGR of 7.27%.
July 2026
The global next-generation cancer therapeutics market size was evaluated at USD 92.54 billion in 2025 and is predicted to hit around USD 186.65 billion by 2035, growing at a CAGR of 7.27%.
July 2026
The global fallopian tube cancer therapeutics market size is expected to increase from USD 1.93 billion in 2025 to hit around USD 5.41 billion by 2035, growing at a CAGR of 10.86%.
June 2026
The breast cancer diagnostics market size is valued at USD 20.14 billion in 2025 and is projected to hit around USD 43.62 billion by 2035 with a CAGR of 8.03%.
June 2026
The global cancer therapeutics and biotherapeutics market size was valued at USD 210.73 billion in 2025 and is expected to hit around USD 475.26 billion by 2035, growing at a CAGR of 8.47%.
June 2026
The global bladder cancer therapeutics diagnostics market size was valued at USD 5.68 billion in 2025 and is expected to hit around USD 10.04 billion by 2035, growing at a CAGR of 5.86%.
May 2026
The global cancer therapeutics market size was evaluated at USD 212.58 billion in 2025 and is expected to surpass around USD 501.07 billion by 2034 with a CAGR of 8.95%.
February 2026
The global esophageal cancer therapeutics market size was evaluated at USD 3.21 billion in 2025 and is predicted to hit around USD 7.75 billion by 2035, growing at a CAGR of 9.22%.
February 2026
The global breast cancer market size was estimated at USD 26.23 billion in 2025 and is projected to hit around USD 40.11 billion by 2035 with a CAGR of 4.34%.
January 2026
The global peptide-based cancer therapeutics market size was evaluated at USD 9.47 billion in 2025 and is predicted to hit around USD 24.85 billion by 2035, growing at a CAGR of 10.13%.
December 2025
The global small cell lung cancer therapeutics market size is projected to hit around USD 22.86 billion by 2035 from USD 7.25 billion in 2025 with a CAGR of 12.17%.
December 2025
The global breast cancer core needle biopsy market size is evaluated at USD 1.03 billion in 2025 and is predicted to hit around USD 1.63 billion by 2035, growing at a CAGR of 4.72%.
July 2025
The pet cancer therapeutics market size was estimated at USD 448.03 million in 2023 and is projected to surpass around USD 1,150.70 million by 2034 with a CAGR of 9.89%.
June 2025
The global colorectal cancer therapeutics market size is expected to hit around USD 19.95 billion by 2034 from USD 12.79 billion in 2024 with a CAGR of 4.55%.
February 2025
The lung cancer therapeutics market size is valued at USD 35.37 billion in 2025 and is expected to hit around USD 76.65 billion by 2035, growing at a CAGR of 8.04%.
June 2025
The automated breast ultrasound systems market size was evaluated at USD 2.21 billion in 2024 and is expected to surpass around USD 10.11 billion by 2034, at a CAGR of 16.70%.
August 2026
The cancer biopsy market size is estimated at USD 36.55 billion in 2025 and is expected to hit around USD 196.68 billion by 2035, growing at a CAGR of 18.33%.
August 2026
The cancer immunotherapy market size is calculated at USD 136.39 billion in 2025 and is projected to hit around USD 367.63 billion by 2035, at a CAGR of 10.42%.
August 2026
The oncology/cancer drugs market size is calculated at USD 192.39 billion in 2025 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
August 2026
The global head and neck cancer drugs market size surpassed USD 18.78 billion in 2025 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
August 2026
The global targeted therapeutics market size was estimated at USD 85.75 billion in 2025 and is projected to hit around USD 163.91 billion by 2035 with a CAGR of 6.69%.
August 2026
The global breast imaging market size is calculated at USD 6.20 billion in 2025 and is projected to hit around USD 14.71 billion by 2035 with a CAGR of 9.29%.
August 2026
The global AI in cancer immunotherapy drugs market size was evaluated at USD 2.80 billion in 2025 and is predicted to hit around USD 27.79 billion by 2035, growing at a CAGR of 25.80%.
July 2026
The global cancer diagnostics market size was exhibited at USD 170 billion in 2025 and is predicted to surpass around USD 378.44 billion by 2035 with a CAGR of 8.33%.
July 2026
The pain management therapeutics market size accounted for USD 88.19 billion in 2025 and is predicted to hit around USD 127.78 billion by 2035, with a CAGR of 3.78%.
July 2026
The global alkaptonuria therapeutics market size is estimated at USD 16.19 million in 2025 and is expected to hit around USD 32.27 million by 2035, growing at a CAGR of 7.14%.
July 2026
The global digital therapeutics market size was exhibited at USD 9.73 billion in 2025 and is projected to surpass around USD 65.31 billion by 2035, with a remarkable CAGR of 20.97%.
July 2026
The global blood cancer diagnostics market size is estimated to hit around USD 22.55 billion by 2035 increasing from USD 11.65 billion in 2025, with a CAGR of 6.83%.
July 2026
The global genomics in cancer care market size was evaluated at USD 24.39 billion in 2025 and is predicted to hit around USD 108.69 billion by 2035, growing at a CAGR of 28.32%.
July 2026
The psoriatic arthritis therapeutics drugs market is growing with rising demand for biologics, biosimilars, and advanced targeted treatment options.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com